Results 181 to 190 of about 139,183 (310)

Autoantibodies to B Lymphocytes in a Patient with Hypoimmunoglobulinemia [PDF]

open access: bronze, 1977
Thomas Tursz   +4 more
openalex   +1 more source

Emergence of bullous pemphigoid under treatment of mycosis fungoides with mogamulizumab

open access: yesJEADV Clinical Practice, EarlyView.
Abstract Mycosis fungoides (MF) is the most common cutaneous T cell lymphoma. Since 2018, mogamulizumab, an antibody directed to to the chemokine receptor CCR4, is licensed for the treatment of MF. Treatment with mogamulizumab is associated with the precipiation of different types of skin rashes summarized as mogamulizumab‐associated rash.
Lukas D. Uleer   +6 more
wiley   +1 more source

Gleich syndrome and eosinophilic fasciitis overlap successfully treated with mepolizumab

open access: yes, 2022
The Journal of Dermatology, Volume 49, Issue 12, Page 1348-1350, December 2022.
Thilo Gambichler   +4 more
wiley   +1 more source

Proteome-Wide Analysis of Autoantibodies in Open-Angle Glaucoma in Japanese Population: A Pilot Study. [PDF]

open access: yesBiomedicines
Takada N   +16 more
europepmc   +1 more source

Rapid and Sustained Improvement of Lichen Planus Pemphigoides With the JAK1 Inhibitor Upadacitinib

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Lichen planus pemphigoides (LPP) is a rare autoimmune blistering disorder characteris ed by lichenoid plaques and blister formation. Current treatments are often ineffective, and there is a lack of standardised guidelines. The disease's pathogenesis involves both T‐cell‐mediated lichenoid dermatitis and autoantibody formation, presenting ...
Louise Gueissaz   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy